Funding in the amount of $2.0M from Japanese strategic investor, in the form of common equity PIPE with warrants. New funding provides for necessary resources to regain compliance with reporting obligations and listing standards. Share trading will move to the OTC Expert Market temporarily, with potential to uplist to OTCQB as soon as SEC filings […] The post NKGen Biotech Announces New Funding to Regain Compliance with Reporting Obligations and Listing Standards first appeared on NKGen Bio...
